Business context and reporting period
This is Welsbach Technology Metals Acquisition Corp.’s Form 10-K for the fiscal year ended December 31, 2023, filed April 16, 2024—not an operating-company 10-K filed under the name Evolution Metals & Technologies Corp. Welsbach was a SPAC seeking a business combination in the technology-metals and energy-transition-materials sectors; it had no operating business or revenue during the year.
After year-end, Welsbach announced a business combination agreement with Evolution Metals LLC on March 29, 2024. The filing does not report a completed transaction or assure that it will close.
Financial results and condition
| Metric | 2023 | 2022 |
|---|---|---|
| Operating revenue | None | None |
| General and administrative expense | $2.023 million | $3.131 million |
| Interest income from trust investments | $2.169 million | $1.121 million |
| Net loss | $54,322 | $2.391 million |
| Net cash used in operating activities | $1.347 million | $976,306 |
Net loss narrowed substantially, reflecting lower operating expenses and higher trust-account interest income. Margins are not meaningful because the company had no revenue.
At December 31, 2023, cash in the trust account was $23.769 million; operating cash was $6,760 and restricted cash was $161,449. Current liabilities were $6.649 million, total liabilities were $9.353 million, and the working-capital deficit was $6.641 million. Related-party promissory notes and working-capital loans totaled $2.845 million; a further $2.705 million deferred underwriting fee is payable only if a business combination is completed. The company reported no long-term debt or off-balance-sheet arrangements.
Material changes and notable items
- Public stockholders redeemed about 4.098 million shares for approximately $42.6 million in March 2023 and 1.457 million shares for approximately $15.7 million in September 2023. The trust balance fell from approximately $79.6 million at year-end 2022 to $23.8 million at year-end 2023.
- The combination deadline was extended to June 30, 2024, with no trust contribution required for the September extension. Failure to complete a transaction by that deadline requires liquidation.
- In November 2023, the company moved trust funds from U.S. Treasury obligations into an interest-bearing deposit account to mitigate potential Investment Company Act concerns.
- A $583,520 excise-tax liability was recorded in connection with 2023 redemptions. The filing says it does not affect the statement of operations.
- The company reported a temporary restricted-cash deficiency during 2023; sponsor funding replenished the restricted balance, and an affiliate backstop agreement covered any year-end deficiency.
Outlook, risks and contingencies
The company had no revenue and depended on completing a business combination and obtaining financing to fund operations. Management and the auditor identified substantial doubt about the company’s ability to continue as a going concern; the auditor’s opinion on the financial statements was unmodified but included a going-concern explanatory paragraph. Sponsor and other related-party funding was not guaranteed. The filing provides no operating guidance or revenue forecast.
Key risks include missing the June 30, 2024 deadline, inadequate funds to pursue or close a transaction, further redemptions, claims against trust assets, and conflicts of interest involving the sponsor and insiders. Nasdaq’s minimum-holder deficiency was confirmed cured in April 2024. The filing also notes economic, market and geopolitical uncertainty.
Important facts for investors to verify
- Whether the March 29, 2024 business combination agreement with Evolution Metals LLC remains in effect, its terms, required approvals and expected closing conditions.
- The current trust balance, redemption activity and cash available to the combined company after transaction costs and any further redemptions.
- How the $2.845 million of related-party notes and working-capital loans, deferred underwriting fee and excise-tax liability will be settled or treated at closing.
- Whether the sponsor backstop fully covers restricted-cash obligations and whether any claims could reduce trust assets.
- Whether the transaction can close by June 30, 2024, and the consequences for public shareholders if it does not.